Who we are

BERANN Biotech is a dermatology‑focused R&D start‑up and spin‑off of Cerepharma SA. We create topical bioactive complexes and peptides that support healthy cell signaling in the epidermis and dermis. Our goal: measurably better skin function—seen as improved barrier performance, reduced visible reactivity, and smoother, more elastic skin over time.

• Targeted signaling
• Peptide‑centric: de‑novo motif design, modifications for stability & permeability, clean sequences suited for cosmetic dossiers.
• Formulation science: ethosomes/liposomes, polymeric hydrogels, gentle solvents, skin‑identical lipids; focus on shelf‑life and ICH‑aligned stability.
• Validation: in‑vitro & ex‑vivo human skin models, barrier and cytokine panels, image‑based morphometrics; dermatological testing with external partners.

We start from skin biology (not disease claims), optimizing signals the skin already uses—so outcomes feel natural and look real.

We co-develop ingredients and prototypes for dermatology, aesthetics, and premium skincare.